BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis

被引：33

作者：

Bukhari, Marwan ^{[1
]}

Abernethy, Rikki ^{[2
]}

Deighton, Chris ^{[3
]}

Ding, Tina ^{[3
]}

Hyrich, Kimme ^{[4
]}

Lunt, Mark ^{[4
]}

Luqmani, Raashid ^{[5
]}

Kiely, Patrick ^{[6
]}

Bosworth, Ailsa ^{[7
]}

Ledingham, Jo ^{[8
]}

Oestoer, Andrew ^{[9
]}

Gadsby, Kate ^{[1
]}

McKenna, Frank ^{[10
]}

Finney, Diana ^{[11
]}

Dixey, Josh ^{[12
]}

机构：

[1] Royal Lancaster Infirm, Dept Rheumatol, Univ Hosp Morecambe Bay NHS Fdn Trust, Lancaster LA1 4RP, England

[2] St Helens Hosp, Dept Rheumatol, St Helens, Merseyside, England

[3] Derbyshire Royal Infirm, Dept Rheumatol, Derby DE1 2QY, England

[4] Univ Manchester, Arthrit Res UK Unit, Manchester, Lancs, England

[5] Nuffield Orthopaed Ctr, Dept Rheumatol, Oxford OX3 7LD, England

[6] St Georges Healthcare, Dept Rheumatol, London, England

[7] Natl Rheumatoid Arthrit Soc, Maidenhead, Berks, England

[8] Queen Alexandra Hosp, Rheumatol Unit, Portsmouth, Hants, England

[9] Addenbrookes Hosp, Dept Rheumatol, Cambridge, England

[10] Trafford Gen Hosp, Dept Rheumatol, Manchester, Lancs, England

[11] Worthing & Southlands NHS Trust, Rheumatol Unit, Oswestry, Shrops, England

[12] Robert Jones & Agnes Hunt Orthopaed Hosp, Dept Rheumatol, Oswestry SY10 7AG, Shrops, England

来源：

RHEUMATOLOGY | 2011年 / 50卷 / 12期

关键词：

Guideline; Rituximab; Rheumatoid arthritis; Eligibility; Safety; THERAPY;

D O I：

10.1093/rheumatology/ker106a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2311 / 2313

页数：3

共 5 条

[1] BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy [J].

Deighton, Chris ;

Hyrich, Kimme ;

Ding, Tina ;

Ledingham, Jo ;

Lunt, Mark ;

Luqmani, Raashid ;

Kiely, Patrick ;

Bukhari, Marwan ;

Abernethy, Rikki ;

Ostor, Andrew ;

Bosworth, Ailsa ;

Gadsby, Kate ;

McKenna, Frank ;

Finney, Diana ;

Dixey, Josh .

RHEUMATOLOGY, 2010, 49 (06) :1197-1199

[2] BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies [J].

Ding, Tina ;

Ledingham, Jo ;

Luqmani, Raashid ;

Westlake, Sarah ;

Hyrich, Kimme ;

Lunt, Mark ;

Kiely, Patrick ;

Bukhari, Marwan ;

Abernethy, Rikki ;

Bosworth, Ailsa ;

Ostor, Andrew ;

Gadsby, Kate ;

McKenna, Frank ;

Finney, Diana ;

Dixey, Josh ;

Deighton, Chris .

RHEUMATOLOGY, 2010, 49 (11) :2217-2219

[3] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[4]

*NAT I HLTH CLIN E, RIT TREATM RHEUM ART

[5] Consensus statement on the use of rituximab in patients with rheumatoid arthritis [J].

Smolen, J. S. ;

Keystone, E. C. ;

Emery, P. ;

Breedveld, F. C. ;

Betteridge, N. ;

Burmester, G. R. ;

Dougados, M. ;

Ferraccioli, G. ;

Jaeger, U. ;

Klareskog, L. ;

Kvien, T. K. ;

Martin-Mola, E. ;

Pavelka, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :143-150

← 1 →